Insights into the treatment of metastatic breast cancer in post-menopausal women: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, increases the expression of pro-apoptotic protein BTG2 via down regulation of its target gene, 13/April/2014, 8.43 am

Insights into the treatment of metastatic breast cancer in post-menopausal women: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, increases the expression of tumor suppressor TPM1 via down regulation of its target gene, 13/April/2014, 8.37 am
April 13, 2014
Insights into the treatment of metastatic breast cancer in post-menopausal women: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, suppresses the expression of telomerase via down regulation of its target gene, 13/April/2014, 8.45 am
April 13, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Insights into the treatment of metastatic breast cancer in post-menopausal women: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, increases the expression of pro-apoptotic protein BTG2 via down regulation of its target gene, 13/April/2014, 8.43 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.